Change in fear of falling in Parkinson's disease: a two-year prospective cohort study.


Journal

International psychogeriatrics
ISSN: 1741-203X
Titre abrégé: Int Psychogeriatr
Pays: England
ID NLM: 9007918

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 18 11 2017
medline: 19 12 2019
entrez: 18 11 2017
Statut: ppublish

Résumé

ABSTRACTBackground:Fear of falling in Parkinson's disease (PD) has been suggested as predictor of future falling. The purpose of this study was to compare fear of falling score after two years of follow-up with those observed at baseline and to assess factors associated with change in fear of falling over time. A total of 120 consecutive persons with PD were recruited and followed for two years. Fear of falling was assessed by using the 10-item Falls Efficacy Scale (FES). Occurrence of falling was registered during the first year of follow-up. After two years, the average FES score statistically significantly changed (p = 0.003) from 30.5 to 37.5 out of 100 (increase of 22.9%). We observed that median scores of all FES items, except for "Preparing a meal, not requiring carrying of heavy or hot objects" and "Personal grooming," significantly increased after two-year follow-up. After accounting for age, gender, PD duration, levodopa dosage, Hoehn and Yayhr stage, Unified Parkinson's Disease Rating Scale score three, depression, anxiety, and falling, we observed that sustaining greater number of falls in the first year of follow-up was associated with higher increase in FES score after two years (odds ratio 3.08, 95% confidence interval 1.30-4.87). After two years of follow-up, we observed a decrease in confidence at performing nearly all basic daily activities. Fall prevention programs should be prioritized in management of PD.

Identifiants

pubmed: 29145921
pii: S1041610217002514
doi: 10.1017/S1041610217002514
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-20

Auteurs

Tatjana Gazibara (T)

Institute of Epidemiology,Faculty of Medicine,University of Belgrade,Belgrade,Serbia.

Darija Kisic Tepavcevic (DK)

Institute of Epidemiology,Faculty of Medicine,University of Belgrade,Belgrade,Serbia.

Marina Svetel (M)

Clinic of Neurology,Clinical Centre of Serbia,Faculty of Medicine,University of Belgrade,Belgrade,Serbia.

Aleksandra Tomic (A)

Clinic of Neurology,Clinical Centre of Serbia,Faculty of Medicine,University of Belgrade,Belgrade,Serbia.

Iva Stankovic (I)

Clinic of Neurology,Clinical Centre of Serbia,Faculty of Medicine,University of Belgrade,Belgrade,Serbia.

Vladimir S Kostic (VS)

Clinic of Neurology,Clinical Centre of Serbia,Faculty of Medicine,University of Belgrade,Belgrade,Serbia.

Tatjana Pekmezovic (T)

Institute of Epidemiology,Faculty of Medicine,University of Belgrade,Belgrade,Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH